About Index Trending news
Analyze
Pricing

Therapeutics

100+ Companies
More info
Upgrade your account to download a CSV export of all the companies on this list Upgrade account

Parent markets

Medical Health Care

Submarkets

No submarkets

Sibling markets

Health and Insurance Medical Devices Pharmaceuticals Medical Professionals Hospitals Clinical Trials Diagnostics

Related markets

Networking Video Software

100+ companies in Therapeutics
Show all

Takeda

Takeda

Pharmaceuticals +1
Seattle Genetics

Seattle Genetics

Health Care +2
Puma Biotechnology

Puma Biotechnology

Biotechnology +1
Neuronetics, Inc.

Neuronetics, Inc.

Biotechnology +2
Neos Therapeutics, Inc.

Neos Therapeutics, Inc.

Biotechnology +2
Savara Pharmaceuticals

Savara Pharmaceuticals

Biotechnology +2
Cidara Therapeutics

Cidara Therapeutics

Health Care +2
Aspyrian Therapeutics

Aspyrian Therapeutics

Biotechnology +1
Iterum Therapeutics

Iterum Therapeutics

Therapeutics
Rigontec GmbH

Rigontec GmbH

Medical +2
Aimmune

Aimmune

Health and Wellness +2
Appili Therapeutics

Appili Therapeutics

Biotechnology +2
Circle Pharma

Circle Pharma

Biotechnology +2
Zavante Therapeutics, Inc.

Zavante Therapeutics, Inc.

Medical +2
Acer Therapeutics Inc.

Acer Therapeutics Inc.

Medical +2
All companies in Therapeutics
Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

News

Funding rounds

Acquisitions

Companies

Investors
13 Oct 2017
InflaRx
InflaRx
$55,000,000
Venture capital (Series D)
Bain Capital Life Sciences LP, Cormorant Asset Management LLC, RA Capital Management LLC

German biopharma company InflaRx racks up $55 mln Series D

PE Hub
02 Oct 2017
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc.
$76,000,000
Venture capital
Flagship Ventures, Polaris Partners, ARCH Venture Partners, +1

KSQ Therapeutics rakes in $76 mln

PE Hub
31 Jul 2017
CerSci Therapeutics
CerSci Therapeutics
$1,650,000
Grant
National Institute on Drug Abuse (NIDA)

UT Dallas Startup Develops Technology to Battle Opioid Epidemic

D Healthcare Daily
26 Jul 2017
Complexa
Complexa
$62,000,000
Venture capital (Series C)
NEA, HBM Healthcare Investments, Edmond de Rothschild Investment Partners, +1

Complexa lands $62 mln Series C

PE Hub
21 Jul 2017
BrainStorm Cell Therapeutics
BrainStorm Cell Therapeutics
$16,000,000
Grant
California Institute for Regenerative Medicine

Brainstorm Awarded $16 Million Non-Dilutive Grant from CIRM in Support of Phase 3 Clinical Trial of NurOwn® in ALS

prnewswire
20 Jul 2017
Aspyrian Therapeutics
Aspyrian Therapeutics
$15,100,000
Venture capital (Series B)
Hiroshi Mikitani

Aspyrian Therapeutics Raises $15.1 Million | San Diego Business Journal

sdbj
17 Jul 2017
AntriaBio
AntriaBio
$13,000,000
Post-IPO equity
Medici Investment, Ildong Pharmaceutical, Aju Pharma

Pharmaceutical firm in Louisville raises $13 million

BizWest
17 Jul 2017
Sphere Fluidics Ltd
Sphere Fluidics Ltd
$1,250,000
Grant
Innovate U.K., University of Edinburgh, Twist Bioscience, +1

Sphere Fluidics Limited and Partners Win Major InnovateUK Grant to Develop the World's First Desktop Genome Editing System

prnewswire
07 Jul 2017
GigaGen
GigaGen
$35,000,000
Undisclosed funding
Grifols

Grifols acquires minority stake in US biotech firm

thepharmaletter
+1
03 Jul 2017
Antag Therapeutics
Antag Therapeutics
$2,370,000
Seed fund
Novo Seeds

This Danish Biotech Thinks it Can Tackle the Obesity Epidemic

Labiotech.eu
+1
29 Jun 2017
Synspira
Synspira
$8,000,000
Seed fund

Synspira Announces $8 Million in Funding and Board of Directors

businesswire
28 Jun 2017
Mersana Therapeutics
Mersana Therapeutics
$75,000,000
IPO

VC-backed Mersana Therapeutics debuts IPO

PE Hub